EBM HDPE pharmaceutical tablet bottles are historically the dominant pharmaceutical solid dosage packaging material globally (HDPE 120cc tablet bottle is the global OTC and Rx pharmaceutical industry standard, produced by EBM at multi-million annual volumes by US, European and Korean pharmaceutical packaging companies). IBM PP and HDPE pharmaceutical tablet bottles compete with EBM HDPE for Korean MFDS-registered pharmaceutical product packaging where three IBM advantages are commercially significant. CRC compliance: IBM 38\/400 or 33\/400 CRC neck OD \u00b10.05mm produces consistent child-resistant closure engagement force at EN ISO 8317 panel testing; EBM HDPE CRC neck \u00b10.15\u20130.30mm produces CRC engagement force variability that can cause EN ISO 8317 test failures at Korean pharmaceutical product registration CRC compliance evaluation stage. Induction seal completeness: IBM flat mouth face (flatness \u00b10.05mm across full face circumference, no parting line step across mouth) provides 360\u00b0 complete induction foil bond; EBM HDPE mouth face may have a parting line step (0.05\u20130.15mm height) across the mouth that creates an incomplete induction seal bond zone at the parting line intersection, a potential moisture ingress point for moisture-sensitive tablet formulation. Tablet pharmaceutical IBM body profile: IBM pharmaceutical tablet bottle can be moulded with internal desiccant canister shelf, pour-guidance internal shoulder step for tablet counting aid, or graduated neck-to-body geometry for label printing station alignment at pharmaceutical filling line \u2014 features that EBM HDPE cannot achieve without secondary moulding operations adding cost and lead time.<\/p>\n<\/div>\n
\n
Desiccant Integration in IBM Pharma Tablet Bottle<\/p>\n
Moisture-sensitive pharmaceutical tablets (hygroscopic active pharmaceutical ingredients: aspirin, ibuprofen, metformin, vitamin C effervescent tablet) require additional moisture protection beyond the IBM bottle wall MVTR \u2014 achieved by integrating a desiccant into the IBM pharmaceutical tablet bottle at filling. Desiccant integration options for IBM PP or HDPE pharmaceutical tablet bottle: canister desiccant (standard silica gel or molecular sieve desiccant in a mini canister inserted into the IBM tablet bottle alongside the tablets at pharmaceutical filling line \u2014 canister OD sized to IBM bottle body ID at bottle mouth opening; IBM bottle mouth ID \u00b10.05mm from IBM core rod neck OD ensures consistent canister drop-in insertion at pharmaceutical line automated canister insertion station at 200\u2013400 bottles\/minute); integrated desiccant shelf: IBM blow mould cavity body includes an internal shelf (formed as an inward-projecting ring in the IBM body wall at 30\u201340% from bottle base) for desiccant placement \u2014 tablets fill above the shelf, desiccant sits on the shelf below tablets, providing dedicated desiccant compartment without canister falling among tablets in consumer use; induction-sealed desiccant packet: foil desiccant sachet heat-sealed at the same induction step as the bottle mouth foil seal \u2014 desiccant sachet inside IBM bottle with induction foil seal above provides integrated moisture control without canister insertion. Korea Ever-Power Ansan-si IBM pharmaceutical tablet bottle programmes coordinate desiccant integration method with pharmaceutical brand at mould design stage, designing IBM bottle body ID, mouth opening and internal shelf geometry (if applicable) to accommodate the pharmaceutical brand\u2019s selected desiccant format from Korean pharmaceutical packaging supplier.<\/p>\n<\/div>\n<\/div>\n<\/section>\n\n\n
<\/div>\n
\n
ABSCHNITT 02<\/p>\n
HDPE vs PP IBM for Solid Dosage: Moisture Barrier and USP Compliance<\/h2>\n<\/div>\n<\/div>\n\n
\n\n\nEIGENTUM<\/th>\n PP IBM<\/th>\n HDPE IBM<\/th>\n PHARMA RECOMMENDATION<\/th>\n<\/tr>\n<\/thead>\n \n\nMoisture barrier (MVTR at 1.0mm wall)<\/td>\n 0.5\u20131.5 g\/m\u00b2\/day (38\u00b0C\/90% RH, ASTM E96B) \u2014 adequate for OTC supplement tablet at 24-month shelf life with desiccant<\/td>\n 0.2\u20130.5 g\/m\u00b2\/day \u2014 2\u20134\u00d7 lower than PP; preferred for moisture-critical Rx tablet (ICH Q1A stability 40\u00b0C\/75% RH MVTR test)<\/td>\n HDPE IBM for Rx solid dosage and moisture-sensitive OTC; PP IBM for standard OTC vitamin with desiccant<\/td>\n<\/tr>\n \nUSP <661> compliance<\/td>\n PP compliant with USP <661> Plastic Packaging Systems test; PP extracts non-volatile residue and metal ion within USP limits. Korea Ever-Power provides USP <661> test data from Korean KOLAS-accredited laboratory for IBM PP pharmaceutical tablet bottle<\/td>\n HDPE compliant with USP <661>; HDPE USP Type II or III depending on HDPE density and crystallinity grade. Korea Ever-Power specifies pharmaceutical-grade HDPE resin (USP Type II from LG Chem or Lotte Chemical) for IBM Rx pharmaceutical tablet bottle<\/td>\n Both PP and HDPE IBM USP <661> compliant with pharmaceutical-grade resin and Korea Ever-Power material documentation<\/td>\n<\/tr>\n \nLight transmission (UV protection)<\/td>\n PP natural: 20\u201340% light transmission (partial UV protection). Amber PP: <5% UV at 400nm (amber iron oxide masterbatch 2\u20134%) \u2014 adequate UV protection for photosensitive Vitamin D, B12, folic acid tablet in amber PP IBM bottle<\/td>\n HDPE white (opaque): <1% light transmission (excellent UV protection from TiO2 masterbatch 2\u20133%). HDPE natural: 20\u201335% transmission. Amber HDPE: <5% UV at 400nm for photosensitive pharmaceutical active<\/td>\n Amber PP or HDPE for photosensitive tablet (Vitamin D, B12); white HDPE for opaque UV-protect Rx solid dosage<\/td>\n<\/tr>\n \nCRC mechanism performance<\/td>\n PP preferred for CRC push-and-turn pharma tablet bottle: PP neck dimensional stability over 24-month shelf life better than HDPE at elevated temperature (PP lower thermal expansion than HDPE at 40\u00b0C ICH accelerated storage) maintains CRC engagement force within EN ISO 8317 range over full Rx shelf life<\/td>\n HDPE CRC tablet bottle: adequate; HDPE thermal expansion at 40\u00b0C ICH accelerated storage slightly increases neck OD (<0.05mm) over 6 months \u2014 may require CRC supplier confirmation that engagement force remains within EN ISO 8317 pass range at HDPE neck upper thermal dimension<\/td>\n PP IBM preferred for CRC Rx tablet bottle (better CRC force stability at accelerated storage temperature)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/section>\n\n\n
<\/div>\n
\n
ABSCHNITT 03<\/p>\n
CRC and Induction Seal IBM Tablet Bottle Neck Design<\/h2>\n<\/div>\n<\/div>\nKorea Ever-Power IBM pharmaceutical tablet bottle mould tooling at Ansan-si \u2014 injection cavity (left) and core rod (centre) for 100ml PP pharmaceutical tablet bottle on ZQ40. The 33\/400 CRC push-and-turn neck is injection-formed at ZQ Station 1 with \u00b10.05mm OD at three circumferential measurement positions. The IBM injection cavity neck section includes: CRC engagement ledge (circumferential step below thread for CRC push-down travel distance); thread profile (33mm OD, 400 series single-start thread for CRC closure screw engagement after push); and mouth face (flat annular surface, Ra \u22640.4\u03bcm at Korea Ever-Power Ansan-si injection cavity polishing) for induction foil seal bond. The IBM core rod forms the inner bore at flat mouth face inner edge for consistent induction seal foil contact area across the full IBM neck mouth circumference.<\/figcaption><\/figure>\n\n
\n
CRC Neck IBM Design for Pharma Tablet Bottle<\/p>\n
Standard Korean and global pharmaceutical CRC neck sizes for IBM tablet and capsule bottles: 33\/400 CRC (33mm OD, 400 series thread) \u2014 most common Korean pharmaceutical tablet bottle CRC neck for 60ml\u2013200ml tablet bottle; 38\/400 CRC (38mm OD) for 200ml\u2013500ml large-count OTC supplement tablet bottle; 28\/400 CRC for 30\u201360ml Rx tablet and hospital unit-dose tablet IBM bottle. IBM CRC neck push-and-turn mechanism design at ZQ Station 1: the CRC closure push-and-turn mechanism requires an IBM bottle neck that provides: push travel zone (typically 2.5\u20134.0mm vertical push travel distance from CRC closure resting position to CRC thread engagement position; IBM injection cavity neck height above the thread top accommodates this push travel); CRC engagement ledge OD (the ledge at the push travel bottom that the CRC thread indexes at completion of push-down, at IBM neck \u00b10.05mm OD); and thread profile (CRC closure thread engages IBM bottle thread for rotation phase after push \u2014 IBM thread profile must match CRC closure thread lead and pitch exactly for smooth push-and-turn operation without cross-thread). Korea Ever-Power Ansan-si validates CRC push-and-turn function at ZQ T1 trial: 50 CRC IBM tablet bottle T1 samples operated by Korea Ever-Power QC team (5 push-and-turn open cycles per bottle) confirming consistent push travel, thread engagement and CRC function across all IBM production cavities before pharmaceutical brand FAI approval of IBM tablet bottle programme.<\/p>\n<\/div>\n
\n
Induction Foil Seal IBM Mouth Face Design<\/p>\n
Induction foil sealing (IFS) on IBM pharmaceutical tablet bottles provides first-opening tamper evidence, primary moisture barrier at the bottle opening, and oxygen exclusion for tablet oxidation-sensitive active (Vitamin C, iron supplement, omega-3 soft gel). IBM tablet bottle mouth face design for complete induction seal bond: mouth face flatness \u00b10.05mm (the IBM bottle mouth face must be flat within \u00b10.05mm across the full annular face width to ensure uniform induction seal foil contact pressure across the full mouth circumference during induction heating at pharmaceutical filling line IFS station). Korea Ever-Power achieves IBM tablet bottle mouth face flatness \u00b10.05mm through: injection cavity mouth face machining at \u00b10.01mm flatness (precision CNC face grinding at Ansan-si mould shop after H13 heat treatment); PP\/HDPE shrinkage compensation at injection cavity mouth face (PP shrinkage at mouth face approximately 0.2\u20130.5mm per 40mm OD mouth face \u2014 Korea Ever-Power designs injection cavity mouth face inner and outer OD slightly undersize to compensate for PP shrinkage, confirming mouth face OD and ID at \u00b10.05mm specification at ZQ T1 trial by physical measurement of 20 IBM tablet bottle samples per cavity). IBM induction seal area confirmation at T1: pharmaceutical brand\u2019s Korean contract packager applies induction foil seal to ZQ T1 IBM tablet bottle samples and checks bond strength (peel force target 3\u20137 N\/mm for PP IBM tablet bottle with standard PE\/EVA induction seal foil) and bond completeness (no unbonded zone at parting line or at 4 circumferential positions under 10\u00d7 magnification) as part of ZQ T1 IBM tablet bottle sample IFS validation report.<\/p>\n<\/div>\n<\/div>\n<\/section>\n\n\n
<\/div>\n
\n
ABSCHNITT 04<\/p>\n
Korean MFDS and Global Regulatory Compliance for IBM Pharma Tablet Bottles<\/h2>\n<\/div>\n<\/div>\n\n
IBM PHARMA TABLET BOTTLE \u00b7 REGULATORY COMPLIANCE BY MARKET<\/p>\n
\n
\n
Korea MFDS<\/p>\n
Korean Ministry of Food and Drug Safety pharmaceutical packaging standard: PP or HDPE IBM tablet bottle must pass Korean Plastic Container Test (Annex 14 of Korean Pharmacopoeia KP) \u2014 elution test in purified water and n-heptane, UV absorbance, non-volatile residue, heavy metal. Korea Ever-Power provides Korean KP compliant IBM PP\/HDPE tablet bottle material test data from Korean MFDS-accredited testing laboratory (NIFDS approved) for MFDS pharmaceutical product license application<\/p>\n<\/div>\n
\n
US FDA (USP)<\/p>\n
USP <661> Plastic Packaging Systems: IBM PP and HDPE pharmaceutical tablet bottle material extraction testing (aqueous and non-aqueous extract analysis per USP <661>). USP <671> Containers: permeation testing of IBM tablet bottle wall for moisture transmission (USP moisture transmission test: IBM tablet bottle filled with calcium chloride desiccant, stored at 75% RH, weighed at 14 and 28 days). Korea Ever-Power provides USP <661> and <671> test data from US FDA-recognized testing laboratory for US NDA\/ANDA pharmaceutical product registration with IBM PP\/HDPE tablet bottle container<\/p>\n<\/div>\n
\n
EU (Ph. Eur.)<\/p>\n
European Pharmacopoeia 3.1.3 (PP containers for pharmaceutical use) and 3.1.4 (PE containers for pharmaceutical use): IBM PP and HDPE tablet bottle extraction testing per Ph. Eur. 3.1.3\/3.1.4. EU GMP Annex 15 packaging qualification for IBM tablet bottle at pharmaceutical manufacturing site. Korea Ever-Power provides Ph. Eur. 3.1.3\/3.1.4 compliant material certificates for IBM PP\/HDPE pharmaceutical tablet bottle for EU pharmaceutical marketing authorisation holder packaging qualification documentation<\/p>\n<\/div>\n
\n
CRC Compliance<\/p>\n
EN ISO 8317 (EU and Korean MFDS): IBM tablet bottle + CRC system panel test (80 adults open in 5 minutes; 200 children 42\u201351 months fail 85% in 10 minutes). ASTM D3475 (US): equivalent CRC test protocol for US Rx pharmaceutical product registration. Korea Ever-Power validates IBM tablet bottle CRC neck \u00b10.05mm against CRC supplier\u2019s fitment spec and supplies ZQ T1 IBM bottle samples to pharmaceutical brand\u2019s CRC compliance testing laboratory for EN ISO 8317 panel test before commercial IBM production approval<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\nKorea Ever-Power IBM pharmaceutical tablet bottle mould tooling at Ansan-si \u2014 showing the injection cavity upper section (neck zone) with 33\/400 CRC push-and-turn profile EDM-machined in H13 steel and the induction seal mouth face ground to Ra \u22640.4\u03bcm for complete IFS bond. The CRC engagement ledge (step above the thread at the IBM injection cavity neck bore) provides the push-travel zone for the CRC push-and-turn mechanism. The IBM injection cavity mouth face (annular flat face at the top of the cavity neck bore) is precision-faced to \u00b10.01mm flatness at Korea Ever-Power Ansan-si CNC grinding station, producing IBM pharmaceutical tablet bottle mouth face flatness \u00b10.05mm in production for complete induction foil bond circumferential coverage.<\/figcaption><\/figure>\n\n\n
<\/div>\n
\n
ABSCHNITT 05<\/p>\n
IBM Pharma Tablet Bottle Output: ZQ40 and ZQ60 Production Data<\/h2>\n<\/div>\n<\/div>\n\n
\n\n\nFORMAT<\/th>\n ZQ-MODELL<\/th>\n Karies<\/th>\n Flaschen\/Std.<\/th>\n BOTTLES\/DAY (16HR)<\/th>\n<\/tr>\n<\/thead>\n \n\n30ml Rx tablet bottle (PP white, 28\/400 CRC)<\/td>\n ZQ40<\/td>\n 12<\/td>\n ~7,200<\/td>\n ~115,200<\/td>\n<\/tr>\n \n100ml OTC vitamin tablet (PP amber, 33\/400 CRC)<\/td>\n ZQ40<\/td>\n 8<\/td>\n ~4,800<\/td>\n ~76,800<\/td>\n<\/tr>\n \n150ml supplement capsule (HDPE natural, 33\/400)<\/td>\n ZQ60<\/td>\n 8<\/td>\n ~3,600<\/td>\n ~57,600<\/td>\n<\/tr>\n \n200ml OTC multivitamin (PP white, 38\/400 CRC)<\/td>\n ZQ60<\/td>\n 6<\/td>\n ~2,800<\/td>\n ~44,800<\/td>\n<\/tr>\n \n500ml OTC bulk supplement (HDPE white, 38\/400)<\/td>\n ZQ80<\/td>\n 4<\/td>\n ~1,400<\/td>\n ~22,400<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\nKorea Ever-Power ZQ IBM pharmaceutical tablet bottle production line at Ansan-si \u2014 ZQ40 IBM machine for 100ml PP amber OTC vitamin tablet bottle (8-cavity, 33\/400 CRC neck, amber PP masterbatch with gravimetric dosing) with chilled water circuit, inline weight check conveyor (\u00b12% alarm) and automated packing for Korean pharmaceutical brand and global OTC vitamin export. ZQ40 8-cavity 100ml PP amber tablet bottle: approximately 4,800 bottles\/hour, producing 76,800 pharmaceutical tablet bottles per 16-hour shift at Ansan-si with Korean KP-compliant PP material certification and CRC function batch record for Korean MFDS pharmaceutical product registration documentation.<\/figcaption><\/figure>\n<\/section>\n\n\n
<\/div>\n
\n
ABSCHNITT 06<\/p>\n
Korean OTC Vitamin and Global Rx Pharma IBM OEM Supply<\/h2>\n<\/div>\n<\/div>\n\n
\n
Korean OTC Vitamin IBM Tablet Bottle Market<\/p>\n
The Korean OTC vitamin and health supplement tablet bottle market (estimated KRW 2.5\u20133.5 trillion total Korean health supplement product value, with pharmaceutical tablet bottle IBM\/EBM segment approximately KRW 150\u2013250 billion) is served by Korean pharmaceutical packaging companies (Yoona Packaging, Daewoo Packaging, CJ Packaging) and IBM PP\/HDPE tablet bottle manufacturers for Korean OTC vitamin brands (CJ CheilJedang Healthone vitamin C, GC Pharma Vitavitamin D, Yuhan vitamin supplement, Korean Centrum distributor). Korea Ever-Power Ansan-si IBM pharmaceutical tablet bottle supply to Korean OTC vitamin brand: ZQ40 and ZQ60 IBM PP amber and white tablet bottle (100ml, 150ml, 200ml OTC vitamin format) with Korean KP pharmaceutical plastic container standard compliance test data from NIFDS-accredited Korean laboratory, EN ISO 8317 CRC function batch record, and Korea Ever-Power ISO 9001:2015 certified production batch documentation for Korean MFDS OTC vitamin product license maintenance. Korean pharmaceutical tablet bottle IBM annual volume: typical Korean OTC vitamin brand requires 2\u201310 million 100ml PP tablet bottles\/year for Korean pharmacy (pharmacies and large-format drugstores Olive Young, Bans Pharmacy) and Korean online pharmacy channel (Korean Naver Shopping prescription-exempt supplement, Korean Coupang OTC vitamin). ZQ40 8-cavity at approximately 4,800 bottles\/hour supplies 23M 100ml PP vitamin tablet bottles\/year per ZQ40 machine at 16hr\/day, 300 days \u2014 adequate for Korean OTC vitamin brand annual volume at approximately 20\u201340% ZQ40 machine utilisation per 10M\/year programme.<\/p>\n<\/div>\n
\n
Global Rx Pharma IBM OEM and K-Pharma Export<\/p>\n
Korean pharmaceutical brands (Hanmi Pharma, Yuhan, Boryung, Daewoong, Chong Kun Dang) expanding global generics and nutraceutical export require IBM PP and HDPE pharmaceutical tablet bottles that satisfy both Korean MFDS and target-market pharmacopoeial standards (USP for US market; Ph. Eur. for EU market; BP for UK market; Japanese Pharmacopoeia JP for Japanese market). Korea Ever-Power provides Korean pharmaceutical brand OEM customers with IBM PP and HDPE tablet bottle multi-market compliance documentation package covering: Korean KP plastic container test (Korean MFDS product registration); USP <661> and <671> test data (US ANDA\/NDA registration with Korean-manufactured IBM tablet bottle container); Ph. Eur. 3.1.3\/3.1.4 compliance certificate (EU marketing authorisation); and EN ISO 8317 CRC panel test certification (EU and UK CRC Rx pharmaceutical labelling requirement). Korea Ever-Power Ansan-si is positioned as a Korean K-pharma IBM tablet bottle supplier supporting Korean pharmaceutical brand global market expansion on the strength of: Korean manufacturing proximity to major Korean pharmaceutical CMO cluster (Osong, Cheongju, Hwaseong Korean pharmaceutical manufacturing zones within 60\u2013120 km of Korea Ever-Power Ansan-si); Korean pharmaceutical regulatory compliance expertise in Korean KP + USP + Ph. Eur. multi-standard IBM tablet bottle documentation; and Korea Ever-Power ISO 9001:2015 quality management system at Ansan-si production supporting Korean pharmaceutical brand supplier qualification audit for pharmaceutical packaging supply chain GMP compliance assessment. Korea Ever-Power provides Korean pharmaceutical brand with site audit access (physical or virtual), pharmaceutical packaging IBM supplier questionnaire response, and manufacturing traceability records at K-pharma IBM tablet bottle programme qualification stage.<\/p>\n<\/div>\n<\/div>\n<\/section>\n\n\n
<\/div>\n
\n
H\u00e4ufig gestellte Fragen zum Thema Technik<\/p>\n
IBM Pharmaceutical Tablet Bottle Engineering Questions<\/h2>\n<\/div>\n<\/div>\n\n
\n
\n
Frage 01<\/span><\/p>\nWhat HDPE specification does Korea Ever-Power recommend for a Korean Rx solid dosage IBM tablet bottle requiring ICH Q1A stability compliance?<\/p>\n<\/div>\n
\n
Korea Ever-Power recommends HDPE pharmaceutical-grade resin at density 0.950\u20130.960 g\/cm\u00b3, MFR 0.3\u20130.8 g\/10min (190\u00b0C\/2.16kg), melt flow index conforming to pharmaceutical-grade specification from Korean HDPE manufacturer (LG Chem XL0900 pharmaceutical HDPE or Lotte Chemical HI900 pharmaceutical grade or equivalent Korean HDPE with pharmaceutical application technical data sheet available), for Korean Rx solid dosage IBM tablet bottle requiring ICH Q1A 40\u00b0C\/75% RH accelerated stability condition compliance. The ICH Q1A accelerated stability requirement for Korean Rx pharmaceutical product registration requires container + pharmaceutical product combination to demonstrate: no unacceptable change in pharmaceutical product appearance, assay, degradation products or dissolution when stored at 40\u00b0C\/75% RH for 6 months in the proposed packaging system. For IBM HDPE pharmaceutical tablet bottle, the relevant ICH Q1A challenge is moisture ingress through the HDPE IBM bottle wall at 40\u00b0C\/75% RH accelerated condition: HDPE IBM tablet bottle moisture transmission at 40\u00b0C\/75% RH (ASTM E96B or USP <671>) target: \u2264100 mg\/day per tablet bottle for moisture-stable Rx active pharmaceutical ingredient (ICH Q1A container performance criterion for most Korean Rx solid dosage pharmaceutical product types). Korea Ever-Power HDPE IBM tablet bottle at 1.2mm body wall, 0.952 g\/cm\u00b3 HDPE density, 33\/400 CRC neck: expected MVTR approximately 15\u201345 mg\/day at 40\u00b0C\/75% RH (significantly below the 100 mg\/day ICH threshold) \u2014 confirmed by USP <671> moisture transmission test at Korea Ever-Power\u2019s contracted Korean pharmaceutical testing laboratory (NIFDS-accredited) before Rx IBM tablet bottle ANDA\/NDA pharmaceutical registration submission with Korean manufactured IBM HDPE tablet bottle container. For highly moisture-critical Rx active (e.g. effervescent tablet with citric acid\/bicarbonate, deliquescent salt API): Korea Ever-Power recommends additional desiccant canister integration in IBM HDPE tablet bottle as primary moisture control and IBM HDPE bottle as secondary moisture control, confirming combined system moisture protection by USP <671> method B (permeation test with desiccant inside IBM HDPE tablet bottle).<\/p>\n<\/div>\n<\/div>\n
\n
\n
Frage 02<\/span><\/p>\nCan Korea Ever-Power produce IBM pharmaceutical tablet bottles in amber PP for photosensitive vitamin D tablets?<\/p>\n<\/div>\n
\n
Korea Ever-Power produces amber IBM PP pharmaceutical tablet bottles for photosensitive vitamin (Vitamin D3, Vitamin B12, folic acid, riboflavin) at ZQ40 and ZQ60 Ansan-si using iron oxide-based amber masterbatch in pharmaceutical-grade PP resin. Amber IBM PP tablet bottle UV protection specification: target UV light transmission <5% at 400nm (ICH Q1B pharmaceutical photostability guideline threshold for amber packaging protection of photosensitive pharmaceutical active) at 1.0\u20131.2mm IBM PP amber bottle wall. Korea Ever-Power standard amber PP masterbatch formulation for pharmaceutical IBM tablet bottle: iron oxide yellow (CI Pigment Yellow 42, Fe2O3\u00b7H2O) + iron oxide red (CI Pigment Red 101, Fe2O3) blend in pharmaceutical PP carrier (approved for indirect food and pharmaceutical contact at iron oxide loading; FDA 21 CFR 178.3297 listed; Korean KP heavy metal limit compliant) at 2.0\u20133.5% total addition in PP resin. UV transmission measurement: Korea Ever-Power submits amber IBM PP tablet bottle wall specimens (25mm diameter discs cut from IBM bottle body at three body positions) to spectrophotometric transmission measurement (300\u2013450nm scan, D65 illuminant) at Korea Ever-Power\u2019s contracted Korean testing laboratory. Pass criterion: T% <5% at all wavelengths 300\u2013400nm (UV range) and <10% at 400\u2013450nm (visible violet range where Vitamin D3 and B12 photodegradation absorption begins). Korea Ever-Power provides amber IBM PP tablet bottle UV transmission measurement report to Korean pharmaceutical brand as part of IBM tablet bottle material certification package for Korean MFDS pharmaceutical product registration submission, confirming ICH Q1B photosensitive product packaging protection requirement is met by amber PP IBM tablet bottle from Korea Ever-Power Ansan-si production.<\/p>\n<\/div>\n<\/div>\n
\n
\n
Frage 03<\/span><\/p>\nWhat is the Korea Ever-Power IBM programme timeline and MOQ for a Korean pharmaceutical brand\u2019s Rx tablet bottle registration package?<\/p>\n<\/div>\n
\n
Korea Ever-Power IBM Rx pharmaceutical tablet bottle programme timeline for Korean pharmaceutical brand Korean MFDS product registration: programme inquiry to mould quotation (days 1\u20135): pharmaceutical brand provides IBM tablet bottle specification (volume, CRC neck size, material PP or HDPE, colour, wall specification, desiccant type); Korea Ever-Power provides IBM mould quotation within 5 Korean business days. Mould design and manufacture (days 5\u201350): H13 steel IBM injection cavity, core rod and blow mould CNC and EDM machining at Ansan-si mould shop for pharmaceutical-grade tablet bottle tooling (injection cavity mouth face polished to Ra \u22640.4\u03bcm for complete IFS bond; CRC neck profile EDM-machined to \u00b10.01mm; wall thickness design from preform wall calculation). T1 mould trial (days 50\u201355): ZQ T1 at Ansan-si produces 200 IBM tablet bottle samples per cavity. T1 sample analysis: dimensional measurement (CRC neck OD, mouth face OD\/ID, flatness, body OD, bottle height), mouth face Ra, bottle weight. CRC fitment test: 50 IBM T1 tablet bottle samples assembled with pharmaceutical brand\u2019s CRC closure and tested for push-and-turn function. IFS bond test: 20 IBM T1 samples IFS-sealed at Korea Ever-Power\u2019s Korean pharmaceutical packaging test partner (automated IFS station at 185\u2013200\u00b0C induction temperature) and peel force measurement at 4 circumferential positions. USP material test sample shipment: 100 IBM T1 samples shipped to Korean NIFDS-accredited pharmaceutical testing laboratory for Korean KP plastic container test. T1 approval by pharmaceutical brand (days 55\u201365): pharmaceutical brand QC review of dimensional and functional data; laboratory acceptance for USP\/KP testing. FAI (days 65\u201375): 50 IBM samples per cavity with full dimensional + CRC + IFS data. Commercial production MOQ: 10,000 IBM tablet bottles (ZQ40 8-cavity at approximately 4,800 bottles\/hour: 10,000 bottles requires approximately 2.1 ZQ40 production hours). First commercial shipment: 7\u201314 Korean business days after pharmaceutical brand FAI written approval. Total Korean pharmaceutical brand IBM registration package timeline: 75\u201390 days from 3D CAD approval to first commercial IBM tablet bottle delivery, including T1 sample and USP\/KP material testing in parallel with ZQ T2 correction (if required).<\/p>\n<\/div>\n<\/div>\n
\n
\n
Frage 04<\/span><\/p>\nWhat are the IBM tablet bottle desiccant canister integration requirements at the pharmaceutical filling line?<\/p>\n<\/div>\n
\n
Desiccant canister integration in IBM PP or HDPE pharmaceutical tablet bottles at the pharmaceutical filling line requires IBM tablet bottle design co-ordination between Korea Ever-Power Ansan-si (IBM bottle inner bore geometry) and the pharmaceutical brand\u2019s Korean desiccant canister supplier (canister OD and length) and pharmaceutical contract packager (filling line automated canister insertion equipment). IBM tablet bottle inner bore diameter for canister insertion: the IBM tablet bottle mouth opening (inner bore at IBM bottle neck, formed by the ZQ core rod neck OD) must be at least 3\u20135mm larger than the canister OD for gravity-drop canister insertion from the pharmaceutical filling line automated canister inserter. Standard Korean pharmaceutical desiccant canisters (Sorbead Korea, Multisorb Korea): 1g canister OD 22mm, length 30mm; 2g canister OD 25mm, length 38mm; 3g canister OD 28mm, length 44mm. IBM tablet bottle inner bore target for desiccant canister: 28mm inner bore (for 25mm OD canister, 3mm gravity-drop clearance) for 150ml IBM PP tablet bottle with 33\/400 CRC neck (core rod neck OD for 33mm CRC neck = approximately 26.5\u201327.5mm inner bore, adequate for 25mm OD canister with 1.5\u20132.5mm clearance for automated canister drop). For 22mm OD canister (1g silica gel) in 100ml IBM PP tablet bottle (core rod neck OD approximately 22\u201324mm inner bore): 0\u20132mm clearance \u2014 marginal for automated canister insertion; pharmaceutical brand must confirm filling line canister insertion speed and drop alignment tolerance with Korea Ever-Power IBM tablet bottle inner bore dimension at ZQ T1 trial canister-fitment test. IBM tablet bottle body ID clearance below neck: IBM tablet bottle body internal diameter (formed by the IBM blow mould cavity body inner OD and the preform outer wall) must accommodate the canister body length \u2014 desiccant canister sitting upright on the IBM tablet bottle base with canister top below the tablet fill level. Korea Ever-Power designs IBM tablet bottle body ID at the bottom zone (below tablet fill height) to be at least 5mm larger than desiccant canister OD for tablet free-fall around canister during pharmaceutical automated tablet counting and bottle filling.<\/p>\n<\/div>\n<\/div>\n
\n
\n
Frage 05<\/span><\/p>\nCan Korea Ever-Power IBM pharmaceutical tablet bottles be labelled directly at filling line without sleeve label?<\/p>\n<\/div>\n
\n
Direct label application to IBM PP or HDPE pharmaceutical tablet bottles without shrink sleeve is the standard Korean pharmaceutical labelling approach for regulated Rx and OTC pharmaceutical product where label format is constrained by Korean MFDS pharmaceutical product label requirements. IBM PP pharmaceutical tablet bottle direct label surface preparation: PP bottle body requires surface energy \u226538 dynes\/cm for self-adhesive PSL (pressure-sensitive label) adhesive bond. Standard PP surface energy as-produced from ZQ IBM at Ansan-si: approximately 29\u201333 dynes\/cm (PP intrinsically low surface energy). Pre-treatment required for PSL direct label on IBM PP tablet bottle: flame treatment (inline flame treater in pharmaceutical label application line at Korean pharmaceutical contract packager \u2014 flame temperature 1,000\u20131,200\u00b0C passes 10\u201320mm above IBM PP tablet bottle body rotating on label station mandrel; flame oxidises PP surface to 38\u201342 dynes\/cm for PSL label adhesion target \u22653 N\/mm peel at 180\u00b0 peel test); or corona pre-treatment (corona discharge station before label application; achieves PP surface energy 40\u201345 dynes\/cm; less common in Korean pharmaceutical packaging line than flame treatment). Label registration accuracy on IBM PP tablet bottle: IBM PP tablet bottle body OD uniformity \u00b10.10mm (versus EBM HDPE \u00b10.3\u20130.5mm body OD variation) ensures consistent label application positioning at pharmaceutical filling line automated labelling station at 200\u2013400 bottles\/minute \u2014 reducing label overlap and label edge misalignment from label station mandrel OD variation correction cycle. Korean MFDS pharmaceutical label compliance: Korean pharmaceutical product label must include Korean language product name, active ingredient, dosage form, strength, manufacturer, expiry date, batch number, storage condition, and MFDS approval number \u2014 IBM PP tablet bottle flat label panel (optional flat panel zone formed in IBM blow mould cavity body by a flat cavity section) provides a preferred label positioning zone for Korean MFDS-regulated pharmaceutical product label at Korean OTC and Rx pharmaceutical retail display and Korean pharmacy dispensing.<\/p>\n<\/div>\n<\/div>\n
\n
\n
Frage 06<\/span><\/p>\nWhat IBM machine and mould investment is required for a Korean pharmaceutical OTC vitamin brand producing 5 million 100ml PP amber tablet bottles per year?<\/p>\n<\/div>\n
\n
Korea Ever-Power IBM machine and mould investment assessment for Korean OTC vitamin brand (100ml PP amber tablet bottle, 33\/400 CRC push-and-turn neck, amber PP with iron oxide masterbatch, 1g desiccant canister, induction foil seal, 5,000,000 bottles\/year programme): ZQ machine selection: ZQ40 with 8-cavity IBM mould at approximately 4,800 100ml PP amber tablet bottles\/hour (from Section 05 output data). Annual capacity per ZQ40 at 16hr\/day, 300 days, 87% OEE: 4,800 \u00d7 16 \u00d7 300 \u00d7 0.87 = approximately 20.0 million 100ml PP amber tablet bottles\/year. Programme capacity utilisation: 5,000,000 \/ 20,000,000 = 25% ZQ40 utilisation. Korea Ever-Power can supply the 5M\/year OTC vitamin tablet bottle programme on shared ZQ40 machine time at Ansan-si (ZQ40 dedicated 25% of annual production schedule to this programme, with remaining 75% available for other IBM programmes). IBM mould investment: 8-cavity ZQ40 100ml PP pharmaceutical tablet bottle mould (H13 steel, 33\/400 CRC neck, induction seal mouth face Ra \u22640.4\u03bcm, amber PP): KRW 14\u201320M for H13 pharmaceutical-grade IBM mould with CRC neck EDM and IFS mouth face precision polishing at Korea Ever-Power Ansan-si. Total Korea Ever-Power IBM investment options for Korean OTC vitamin brand\u2019s 5M\/year 100ml amber tablet bottle programme: Option A (outsourced IBM at Korea Ever-Power Ansan-si \u2014 shared ZQ40): mould investment KRW 14\u201320M + IBM production contract at Korea Ever-Power Ansan-si unit pricing. Korean OTC vitamin brand does not purchase ZQ40 machine; Korea Ever-Power owns and operates ZQ40 machine and supplies finished IBM tablet bottles to Korean OTC vitamin brand at agreed unit price and annual volume commitment. Option B (in-house IBM at Korean OTC vitamin brand or Korean pharmaceutical packaging CMO): Korean vitamin brand or Korean pharma packaging CMO purchases ZQ40 machine from Korea Ever-Power (ZQ40 machine price: USD 45,000\u201365,000 at Korea Ever-Power list price) + IBM mould KRW 14\u201320M, with Korea Ever-Power providing ZQ40 machine installation, commissioning, and operator training at Korean vitamin brand\u2019s Korean facility. Korea Ever-Power recommends Option A (Ansan-si outsourced IBM) for Korean OTC vitamin brand annual volumes <20M\/year (below ZQ40 full capacity utilisation), as Option A avoids capital expenditure on ZQ40 machine ownership and provides access to Korea Ever-Power\u2019s ZQ IBM pharmaceutical production expertise and Korean KP regulatory compliance documentation infrastructure without capital investment by the Korean OTC vitamin brand.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n
\n
<\/div>\n
<\/div>\n
\n
PHARMA TABLET BOTTLE IBM ENQUIRY \u00b7 KOREA EVER-POWER<\/p>\n
Planning a Pharmaceutical Tablet Bottle IBM Programme?<\/h2>\n Korea Ever-Power provides PP and HDPE pharmaceutical tablet IBM bottle mould development, ZQ40\/ZQ60 production, CRC compliance validation, Korean KP and USP material documentation for OTC and Rx pharmaceutical brand OEM from Ansan-si, Gyeonggi-do.<\/p>\n
Request Pharma Tablet IBM Consultation \u2192<\/span><\/a><\/p>\n<\/div>\n<\/div>\n <\/p>\n
Herausgeber: Cxm<\/em><\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"IBM PHARMACEUTICAL TABLET BOTTLE \u00b7 PP HDPE OTC RX \u00b7 CRC INDUCTION SEAL \u00b7 KOREA EVER-POWER ZQ IBM for Pharmaceutical Tablet Bottle Production: OTC and Rx IBM Guide Pharmaceutical tablet and capsule bottles \u2014 OTC vitamin supplement bottles, Rx solid dosage prescription containers, nutraceutical capsule bottles and medical device tablet packaging \u2014 require IBM PP […]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-1271","post","type-post","status-publish","format-standard","hentry","category-application-of-isbm"],"_links":{"self":[{"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/posts\/1271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/comments?post=1271"}],"version-history":[{"count":3,"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/posts\/1271\/revisions"}],"predecessor-version":[{"id":1276,"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/posts\/1271\/revisions\/1276"}],"wp:attachment":[{"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/media?parent=1271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/categories?post=1271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/de\/wp-json\/wp\/v2\/tags?post=1271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}